✦ LIBER ✦

Treatment of SCID/human B cell precursor ALL with anti-CD19 and anti-CD22 immunotoxins

✍ Scribed by Herrera, L; Yarbrough, S; Ghetie, V; Aquino, D B; Vitetta, E S

Book ID: 118676847
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 179 KB
Volume: 17
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2402790

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapy of human B-cell lymphoma bearing

Therapy of human B-cell lymphoma bearing scid mice is more effective with anti-CD19-and anti-CD38-saporin immunotoxins used in combination than with either immunotoxin used alone

✍ David J. Flavell; Deborah A. Boehm; Loretta Emery; Armorel Moss; Alan Ramsay; So 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 885 KB

The CD19+ CD38+ human Burkitt's lymphoma cell line Ramos grows aggressively when injected intravenously (i.v.) into severe combined immunodeficient (SCID) mice, killing 100% of animals within a 3 3 4 2 day period with widely disseminated disease. Treatment commencing 7 days after i.v. injection of R

The anti-CD20 antibody rituximab augment

The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma

✍ David J. Flavell; Sarah L. Warnes; Christine J. Bryson; Sarah A. Field; Armorel 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 548 KB

Treatment of B cells malignancies with a

Treatment of B cells malignancies with anti-CD19 CAR+, TCR-, CD52- allogeneic T cells

✍ Cécile Schiffer Mannioui,Laëtitia Lemaire… 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 71 KB

A phase I study of a combination of anti

A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia

✍ John Schindler; Srikanth Gajavelli; Farhad Ravandi; YuMin Shen; Samir Parekh; Ir 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Anti-CD7 antibody and immunotoxin treatm

Anti-CD7 antibody and immunotoxin treatment of human CD7+T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid mice

✍ Flavell, D J; Warnes, S L; Noss, A L; Flavell, S U 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 90 KB

Anti-CD19 and anti-CD22 monoclonal antib

Anti-CD19 and anti-CD22 monoclonal antibodies increase the effectiveness of chemotherapy in Pre-B acute lymphoblastic leukemia cell lines

✍ C. Stanciu-Herrera; C. Morgan; L. Herrera 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 691 KB